| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 18.97B | 18.86B | 18.40B | 17.18B | 15.74B | 16.42B |
| Gross Profit | 4.16B | 1.95B | 3.95B | 3.30B | 2.30B | 2.79B |
| EBITDA | 3.44B | 3.14B | 3.28B | 2.74B | 2.02B | 2.32B |
| Net Income | 1.13B | 723.22M | 1.07B | 675.33M | 148.51M | 324.00M |
Balance Sheet | ||||||
| Total Assets | 36.61B | 39.41B | 36.66B | 34.55B | 31.29B | 31.78B |
| Cash, Cash Equivalents and Short-Term Investments | 2.52B | 3.57B | 2.55B | 2.38B | 2.58B | 2.49B |
| Total Debt | 14.98B | 17.18B | 13.95B | 12.41B | 11.34B | 11.52B |
| Total Liabilities | 19.66B | 21.75B | 19.58B | 18.32B | 15.89B | 16.25B |
| Stockholders Equity | 16.80B | 17.50B | 16.92B | 16.08B | 15.26B | 15.39B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -1.51B | -1.14B | -1.83B | 664.30M | 348.17M |
| Operating Cash Flow | 0.00 | 695.97M | 1.03B | 1.19B | 2.40B | 2.42B |
| Investing Cash Flow | 0.00 | -2.16B | -1.82B | -3.59B | -1.93B | -1.02B |
| Financing Cash Flow | 0.00 | 2.54B | 958.49M | 1.59B | -388.62M | -624.12M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥21.90B | 11.93 | ― | 4.36% | -0.08% | -1.83% | |
72 Outperform | ¥24.47B | 9.58 | ― | 3.29% | 24.94% | 17.77% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
64 Neutral | ¥46.67B | 5.87 | ― | 2.38% | 38.97% | -8.68% | |
57 Neutral | ¥61.84B | 9.29 | ― | 2.89% | 4.32% | 11.25% | |
52 Neutral | ¥39.73B | 21.02 | ― | 0.45% | 23.11% | 8.31% | |
47 Neutral | ¥7.57B | 10.53 | ― | 5.03% | 2.49% | -32.47% |